Navigation Links
Cortisol and fatty liver: Researchers find cause of severe metabolic disorders
Date:9/9/2008

A healthy body stores fat in the form of so-called triglycerides in specialized fatty tissue as an energy reserve. Under certain conditions the delicate balance of the lipid metabolism gets out of control and fat is accumulated in the liver, leading to the dreaded fatty liver. This increases the risk of many metabolic diseases, such as the metabolic syndrome known as "deadly quartet". This combination of fatty liver, obesity, diabetes and hypertension is regarded as the primary cause of life-threatening vascular events such as myocardial infarction and stroke.

It was still unknown which conditions cause the body to deposit fat in the liver. However, scientists knew that the body's own glucocorticoid hormones such as cortisol promote the development of fatty liver. This can be observed, for example, in a condition known as Cushing syndrome. Cortisol levels in affected patients are permanently raised often caused by malignant tumors. This, in turn, leads to high blood sugar levels and patients frequently develop fatty liver. Long-term cortisone therapies such as those used for treating chronic inflammatory diseases such as asthma also cause the triglyceride level in the liver to rise to dangerous levels. Dr. Stephan Herzig, head of the Junior Research Group "Molecular Metabolic Control" at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), and his team have now published the mechanism by which the body's own glucocorticoid hormones contribute to this disruption of the lipid metabolism.

The researchers in Herzig's team specifically switched off the cortisol receptor in the livers of mice, thus blocking the hormone's effect. As a result, the triglyceride level in the livers of the experimental animals dropped considerably. Investigations have revealed that, in the absence of the cortisol receptor, large amounts of the HES1 protein are produced in the livers of these animals. HES1 activates a number of enzymes that break
'/>"/>

Contact: Dr. Sibylle Kohlstdt
s.kohlstaedt@dkfz.de
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1 2

Related biology news :

1. Omega-3 fatty acids protect against Parkinsons, study says
2. University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
3. Typical North American diet is deficient in omega-3 fatty acids
4. Trans-fatty acids and insulin sensitivity
5. Scientists suspect omega-3 fatty acids could slow acute wound healing
6. Atomic structure of the mammalian fatty acid factory determined
7. Researchers identify proteins involved in new neurodegenerative syndrome
8. Texas researchers and educators head for Antarctica
9. MGH researchers describe new way to identify, evolve novel enzymes
10. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
11. U of MN researchers discover noninvasive diagnostic tool for brain diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., The National Association of Biology Teachers (N...r of biological sciences at Naugatuck Valley Commu...h the 2009 Evolution Education Award during the NA...e held 11-14 November 2009 in Denver, Colorado. ,...the American Institute of Biological Sciences,(AI...
(Date:11/4/2009)..., LEADS: (top news in natural science) , U...d States uses less water today than it did 35 year...eclines in water use are partly attributable to al... efficient irrigation systems. According to the la...er used in the United States goes to cooling therm...
(Date:11/4/2009)..., The Singapore laboratory that deciphered the DN...ish) and elephant shark, has joined The Genome 10K...luable repository of DNA sequences on 10,000 speci...n a scale that currently can not be achieved. , ... in a paper published in the Nov. 5, 2009 issue of...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Singapore scientists join international study of 10,000 vertebrates' genomes 2Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 1Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 2Actelion Launches Increased Strength Formulation of Ventavis 28Iloprost 29 for Pulmonary Arterial Hypertension in the United States 13785 3Government Best Source for U S Hospital Data Study Finds 55940 1Government Best Source for U S Hospital Data Study Finds 55940 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 1Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 2Swine Flu May Be Less Dangerous Than Predicted 3A Study 55938 3
...issue of Nature Genetics, is based on data from mo... already known genes, but also discovered ten new ...y size of about 3.5 centimeters. , The analysis p...eral of the identified genes are targeted by the m...er genes. This connection was completely unknown u...
...the May 2008 Pediatric Academic Societies and Asia...icate that childhood and adolescent obesity negati...relates to cardiac health. , Obesity has been inc...rs and obesity in adults has been linked to cardio...dren is also increasing and many cardiovascular di...
...pped their comfortable offices for one of the most...out a challenging field campaign that is seen as t... mission CryoSat will be as accurate as possible. ...y and Canada, are currently in the middle of CryoS...ive three-week experiment programme in the far nor...
Other Biology News:How body size is regulated 2Study supports reason for concern in childhood and adolescent obesity 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 2Scientists endure Arctic for last campaign prior to CryoSat-2 launch 3
(Date:11/5/2009)....Y., Nov. 5 BioSpecifics...eutical company developing first-in-class collagen...results for the third quarter ended September 30, ...tember of this year, the FDA,s Arthritis Advisory ...-0, the approval of XIAFLEX(TM) for the treatment ...
(Date:11/5/2009)...as, Nov. 5 SpineSmith Partners has...o co-develop a unique scaffold that mimics the str...uation of several commercial products by SpineSmit...ny believes the GenOsteo scaffold represents a sig...unique and ideal environment for the delivery of a...
(Date:11/4/2009)... This webinar, which will be presented on ...n continuous flow chemistry processing, will deal ...ne using various meso and micro scale flow chemist...blications has been recognized with several presti...he 2009 Tetrahedron Prize. , ...
(Date:11/4/2009)... Calif., Nov. 4 Onyx Pha...d that it will present at the Credit Suisse 18th A... 11, at 9:30 a.m. Mountain Time (8:30 a.m. Pacific...ast of the presentation on our website at: http:...,, It is recommended that listeners log on 15 m...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
... in Women,s Health (NPWH) Encourages Women to Get...SHINGTON, Feb. 20 Despite growing awareness of HP...vical cancer, a new survey,released by the Nationa...alth (NPWH) found that many women remain in the da...pite the fact that there is now a vaccine that,can...
...hn,s Disease, Pouchitis and ...era Therapeutics, a,biopharmaceutical company focu...ation of proprietary compounds to treat a broad ra...nounced the completion of a,$35.5 million Series C...estors., New investor Montagu Newhall Associates ...
...627 Million; GAAP EPS $0.34; ...Net Revenue Reaches $2.50 Billion; 2007 GAAP EPS ... CORONA, Calif., Feb. 20 Watson,Pharmaceuticals,...tical,company, today reported fourth quarter and f...r ended December 31, 2007 and provided an outlook ...
Other Biology Technology:Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 2Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 3Survey Shows Most Women Can't Separate Fact From Fiction When It Comes to Cervical Cancer Prevention 4Ocera Therapeutics Closes $35.5 Million Series C Financing 2Ocera Therapeutics Closes $35.5 Million Series C Financing 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 18
Streptavidin, PE conjugated/tagged from Invitrogen
GIBCO RPMI Medium 1640; powder from Invitrogen
...5 ml Dynabeads Tosylactivated (4.5 m). Hydrophobi...tive groups. For coupling of antibodies for cell a... on initial coupling with covalent binding of prim...)) occurringovernight. Coupling reactions can be p...
Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
Biology Products: